Community/Retail

Adam Smith, pharmacy student at Purdue University College of Pharmacy, talks about how he became interested in pharmacy.

Michael Cohen, RPh, MS, ScD, DPS, FASHP, President of the Institute of Safe Medicine (ISMP) discusses how computerized order entry systems may be a source of medication error.

Mollie Scott, PharmD, discusses the role pharmacists can play in meeting new quality measures under a value-based care model.

A male suspect carrying an orange traffic cone and a firearm allegedly robbed a Rite Aid pharmacy before carjacking a priest in the parking lot to escape.

Eli Lilly and Company and Sarah Cannon Research Institute today announced a strategic partnership to co'develop an investigational oncology compound, LY3023414, a PI3K/mTOR dual inhibitor.

Eli Lilly and Company and Dana-Farber Cancer Institute today announced a multiyear collaboration to research new medicines under development to fight cancer.

Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.

More than half of consumers don't understand sun protection factor (SPF) values, providing pharmacists important opportunities to offer sun safety counseling.

Two leading House Republicans expressed concern to TRICARE officials recently regarding patient access to prescribed compounded medications.

CVS Health was honored today by the National Business Group on Health for its ongoing commitment and dedication to promoting a healthy work environment.

The National Business Group on Health today honored Cardinal Health for its ongoing commitment and dedication to promoting a healthy work environment.

Mylan N.V. today issued a statement regarding Abbott Laboratories' announced intention to support Mylan's offer to acquire Perrigo Company plc.

Allergan and KYTHERA Biopharmaceuticals today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire KYTHERA in a cash and equity transaction.

Mollie Scott, PharmD, details the ways in which pharmacists can contribute to patient care in an ambulatory setting despite not having provider status.

Ethan Wahl, pharmacy student at Purdue University College of Pharmacy, talks about what he thinks is the most important issue facing pharmacy.

Mollie Scott, PharmD, describes the role of a pharmacists in providing anticoagulation resources in a transitions of care setting.

Although the world's population is generally living longer today than a decade ago, the vast majority still has a number of health issues.

Abbott today confirmed its continued support for Mylan N.V's growth strategy by stating its intent to vote its 14.5 percent stake in Mylan in favor of Mylan's proposed acquisition of Perrigo.

A new survey published by Pharmacy Times and U.S. News & World Report offers good news for people suffering from chronic pain.

Mollie Scott, PharmD, discusses how pharmacists can help correct the problem of overscreening in patients who don't need it and reaching patient populations currently under screened for a variety of health issues.

Children aged 12 to 17 years with migraines now have a new option for alleviating their symptoms.

Glenmark Pharmaceuticals' levonorgestrel/ethinyl estradiol tablets, a generic version of Teva's Seasonale extended-cycle birth control, have been cleared by the FDA and will begin shipping immediately.

Avella Specialty Pharmacy has just distributed its fourth issue of Dispensing Excellence, a publication aimed at healthcare providers, nurses, medical assistants and their patients.

Concurrently prescribed opioids and benzodiazepines increase the risk for deadly drug overdose in veterans.

CVS Health's move to acquire Target's pharmacy business for $1.9 billion is a game changer in the pharmacy world.

side from the obvious networking and career-advancement benefits, online pharmacy groups provide a number of perks.

A new bill introduced in the US Senate would permit pharmacists to dispense birth control pills without a prescription.

Bayer HealthCare and The Johns Hopkins University in Baltimore, Maryland, U.S., have entered into a five-year collaboration agreement to develop new ophthalmic therapies targeting retinal diseases.